Nitrofurantoin Iasis

Nitrofurantoin, the active ingredient in Nitrofurantoin Iasis, is a nitrofuran antibiotic presented as an oral formulation for systemic use. It treats uncomplicated urinary tract infections and acute cystitis, primarily in adult patients, and concentrates in urine to target common uropathogens such as Escherichia coli and Staphylococcus saprophyticus.

GNH USA supplies Nitrofurantoin Iasis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare institutions worldwide.

Nitrofurantoin is used to treat infections of the urinary tract.

Uncomplicated urinary tract infection: eliminates causative bacteria and resolves urinary symptoms. Acute cystitis: provides bacteriostatic or bactericidal activity to clear bladder infection. Prophylaxis of recurrent urinary tract infection: reduces the frequency of future episodes when used as a preventive regimen.

Adverse reactions may occur with nitrofurantoin use.

Common Side Effects: - Nausea - Vomiting - Loss of appetite - Diarrhea

Serious or Rare Side Effects: - Pulmonary toxicity (including interstitial pneumonitis) - Hepatic injury (hepatitis or cholestasis) - Severe allergic reactions such as Stevens‑Johnson syndrome or anaphylaxis

Nitrofurantoin should be used with appropriate clinical caution. - Renal function: assess creatinine clearance before initiating therapy. - G6PD deficiency: avoid due to risk of hemolytic anemia. - Pregnancy: limit use to situations where benefit outweighs potential risk. - Breastfeeding: monitor infant for possible adverse effects. - Drug interactions: review concomitant medications for potential interactions. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nitrofurantoin may interact with several medicines.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce nitrofurantoin absorption. - Probenecid: decreases renal excretion, increasing systemic exposure. - Warfarin: may enhance anticoagulant effect and increase INR.

Moderate Interactions (Monitor Closely): - Fluoroquinolones: additive risk of neurotoxicity. - NSAIDs: may increase risk of renal impairment. - Vitamin C (high doses): can alter urinary pH and affect drug efficacy.